News

Close ally of drug kingpin ‘El Mencho’ gets 30 years in prison as US ramps up pressure on cartels
“El Mencho’s” son, Rubén Oseguera — known as “El Menchito” — was sentenced to March to life in prison after his conviction in ...
Should the U.S. ban drug advertising to consumers?
The U.S. is rare among Western nations because it allows pharmaceutical advertising. But a new effort aims to stop it. A bill ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...
See nearly 3,000-foot-long drug tunnel found beneath US-Mexico border, feds say
An unfinished tunnel for “large-scale narcotics smuggling” from Tijuana to San Diego under the U.S.-Mexico border has been ...
US FDA approves Gilead's twice-yearly injection for HIV prevention
The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for ...
Border Patrol finds massive drug-smuggling tunnel that linked Mexico to US
U.S. Border Patrol agents have uncovered a sophisticated underground tunnel stretching more than 1,000 feet into the United ...
We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
Medscape3d
How Proposed Tariffs Could Disrupt US Drug Prices and Supply
Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...
How we plan to cut FDA drug approval time by months
Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...
US FDA to shorten review time for drug developers under new voucher program
The regulator said on Tuesday that the commissioner would determine whether a company aligns with health priorities such as ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
Threat in your medicine cabinet: The FDA’s gamble on America’s drugs
The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.